Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Accounts Payable & Accrued Expense : ¥38.3 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co Accounts Payable & Accrued Expense?

Anhui Wanbang Pharmaceutical Technology Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥56.5 Mil) to Dec. 2023 (¥45.3 Mil) and declined from Dec. 2023 (¥45.3 Mil) to Mar. 2024 (¥38.3 Mil).

Anhui Wanbang Pharmaceutical Technology Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥27.5 Mil) to Dec. 2022 (¥46.7 Mil) but then declined from Dec. 2022 (¥46.7 Mil) to Dec. 2023 (¥45.3 Mil).

Anhui Wanbang Pharmaceutical Technology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Anhui Wanbang Pharmaceutical Technology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Wanbang Pharmaceutical Technology Co Accounts Payable & Accrued Expense Chart

Anhui Wanbang Pharmaceutical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

11.34

16.75

27.54

46.69

45.32

Anhui Wanbang Pharmaceutical Technology Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial									-	50.99	56.48	45.32	38.31

Anhui Wanbang Pharmaceutical Technology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000

Website

http://www.ahwbyy.cn

Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines